A randomized clinical trial of home telemonitoring in patients with advanced heart and lung diseases.

Brief Summary: The addition of home monitoring to an integrated care model in patients with advanced chronic heart/lung diseases decreases mortality, hospital and emergency admissions, improves functional status, HRQoL, and is cost-effective.

Background: Telemonitoring is a promising implement for medicine, but its efficacy is unknown in patients with advanced heart and lung failure (AHLF).

Objective: To determine the efficacy of a telemonitoring system added to coordinated clinical care in patients with AHLF.